Latest financial market updates and expert analysis
Analysis For Fibrobiologics, a biotechnology firm, the immediate corporate agenda is dominated by structural and financial reorganization. The market’s attention has shifted away from clinical trial data for the time being,...
The future of entertainment giant Warner Bros. Discovery (A) is now the subject of a high-stakes corporate contest. Two distinct...
Today’s annual general meeting for AiRWA Inc., the company formerly known as Connexa Sports, is drawing significant market attention. The...
The biotechnology firm Alnylam has crossed a significant threshold, reporting its first annual profit under GAAP accounting standards. This achievement,...
Kraft Heinz is embarking on a significant strategic pivot under its new chief executive, Steve Cahillane. The previously approved plan...
The global energy landscape is shifting, and Venture Global finds itself at a pivotal juncture. With short-term market catalysts absent,...
The VanEck Video Gaming and eSports ETF (ESPO) offers targeted exposure to one of the world’s most dynamic long-term growth...
Axsome Therapeutics has released its complete financial results for the fourth quarter and the full fiscal year 2025. Preliminary figures,...
Investors are in a holding pattern as network solutions provider Adtran prepares to release its final, audited financial statements for...
Dorchester Minerals operates with a distinct approach in the energy sector. Unlike traditional exploration and production companies, it holds royalty...
In a move signaling confidence to investors, Altria Group has reaffirmed its full-year adjusted earnings per share (EPS) forecast for...
